Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eden vs Hims

By GLP-1 ScorecardUpdated

Our take

I’d compare Hims if you want a branded prescription and can budget for membership plus medication. If Eden’s advertised compounded offer interests you, ask which agreement applies before counting on the price or guarantee.

Price the actual formulation and care arrangement you want before comparing the combined bills.

Eden
Site position #16

Higher score

HimsFactor scores not reassessed.
Site position #56

Lower score

Score comparison

Eden has the higher recorded score — 81.6/100 to 75.6/100.

Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Before you choose

Hims does not publish a semaglutide price, so its Hims review sets out what it does disclose, while the Eden review explains the conditions attached to Eden's figure. The semaglutide cost page compares published rates across the field. Ask Hims for a written total before treating either one as the cheaper choice.

If neither one fits, Eden vs JM Integrated Health and EOS Health vs Hims compare each of them with another graded program, and the list of alternatives to Eden ranks the programs closest to Eden on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEden +3
85
82
Dose & formulationEden +8
86
78
Clinical oversightEven
55
55
Labs & monitoringEden +12
92
80
FulfillmentEden +9
93
84
Contract termsEden +10
90
80
Eden · top barHims · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdenHims
WeighScore81.6/10075.6/100
GradeB−C
Site position#16#56
SemaglutideAdvertised $99/mo bundle; linked membership terms conflict—confirm checkoutVaries (branded medication plus separate membership)
TirzepatideAdvertised $129/mo bundle; linked membership terms conflict—confirm checkoutVaries (branded medication plus separate membership)
CoverageAll 50 statesSelected states; eligibility varies
Brand-name accessYesYes
Oral / sublingualNot confirmedYes
Eden

Site position #16 · B−

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Strengths

  • Current compounded offer includes medication and support
  • Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
  • Named pharmacy operation and partner network can be investigated

What to consider

  • Linked membership terms describe a separate fee model
  • Landing-page warranty and terms use different thresholds and conditions
  • FDA warning history remains relevant; a new offer does not establish resolution
Hims

Site position #56 · C

Factor scores not reassessed.

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

Strengths

  • Branded oral and injectable options
  • Medication and membership prices presented separately

What to consider

  • Required membership adds to advertised medication prices
  • Membership does not guarantee a prescription

Featured provider

Eden

Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard